Discontinued — last reported Q2 '23
Waste Connections Acquisitions decreased by 66.8% to $63.09M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 83.4%, from $380.42M to $63.09M. Over 4 years (FY 2021 to FY 2025), Acquisitions shows a downward trend with a -3.9% CAGR.
High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.
This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...
Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.
acquisitions| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $58.95M | $493.78M | $399.17M | $355.21M | $191.77M | $725.93M | $933.99M | $144.61M | $68.54M | $360.03M | $103.61M | $1.16B | $279.28M | $574.57M | $110.60M | $380.42M | $130.32M | $116.57M | $190.27M | $63.09M |
| QoQ Change | — | +737.7% | -19.2% | -11.0% | -46.0% | +278.5% | +28.7% | -84.5% | -52.6% | +425.3% | -71.2% | >999% | -75.8% | +105.7% | -80.8% | +243.9% | -65.7% | -10.6% | +63.2% | -66.8% |
| YoY Change | — | — | — | — | +225.3% | +47.0% | +134.0% | -59.3% | -64.3% | -50.4% | -88.9% | +699.7% | +307.5% | +59.6% | +6.8% | -67.1% | -53.3% | -79.7% | +72.0% | -83.4% |